US Stock MarketDetailed Quotes

ARWR Arrowhead Pharmaceuticals

Watchlist
  • 22.610
  • +0.080+0.36%
Close Apr 18 16:00 ET
  • 22.610
  • 0.0000.00%
Post 16:02 ET
2.80BMarket Cap-8162P/E (TTM)

Arrowhead Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
(Q3)Jun 30, 2022
(Q2)Mar 31, 2022
Total revenue
-94.32%3.55M
-1.03%240.74M
-49.02%16.1M
-51.18%15.83M
-3.65%146.27M
127.95%62.55M
75.89%243.23M
-17.52%31.58M
-29.37%32.41M
362.66%151.81M
Operating revenue
-94.32%3.55M
-1.03%240.74M
-49.02%16.1M
-51.18%15.83M
-3.65%146.27M
127.95%62.55M
75.89%243.23M
-17.52%31.58M
-29.37%32.41M
362.66%151.81M
Cost of revenue
Gross profit
Operating expense
33.83%140.1M
5.69%445.74M
7.82%124.43M
12.54%118.53M
-11.02%98.1M
15.34%104.68M
46.78%421.74M
11.86%115.41M
35.45%105.32M
80.61%110.25M
Selling and administrative expenses
12.69%23.19M
-25.96%90.93M
-23.58%24.17M
-28.62%23.37M
-32.62%22.82M
-16.31%20.58M
51.66%122.82M
-17.40%31.62M
83.33%32.74M
109.16%33.86M
-General and administrative expense
12.69%23.19M
-25.96%90.93M
-23.58%24.17M
-28.62%23.37M
-32.62%22.82M
-16.31%20.58M
51.66%122.82M
-17.40%31.62M
83.33%32.74M
109.16%33.86M
Research and development costs
39.19%116.49M
18.80%353.19M
19.76%99.86M
31.28%94.76M
-1.45%74.88M
27.26%83.7M
44.08%297.31M
26.78%83.38M
21.67%72.18M
70.00%75.99M
Depreciation amortization depletion
2.23%412K
0.19%1.62M
0.25%405K
0.25%404K
0.25%405K
0.00%403K
--1.61M
--404K
-30.16%403K
158.97%404K
-Depreciation and amortization
2.23%412K
0.19%1.62M
0.25%405K
0.25%404K
0.25%405K
0.00%403K
--1.61M
--404K
-30.16%403K
158.97%404K
Operating profit
-224.07%-136.55M
-14.84%-205M
-29.23%-108.33M
-40.86%-102.7M
15.91%48.17M
33.46%-42.13M
-19.77%-178.51M
-29.20%-83.83M
-128.78%-72.91M
247.18%41.55M
Net non-operating interest income expense
-1,435.93%-2.57M
-160.14%-3.03M
-186.99%-1.38M
-179.52%-986K
-147.15%-497K
-114.45%-167K
-17.76%5.03M
37.89%1.58M
-3.13%1.24M
-30.84%1.05M
Non-operating interest income
4.47%2.8M
203.97%15.3M
145.42%3.89M
236.45%4.17M
332.64%4.56M
--2.68M
-17.76%5.03M
--1.58M
--1.24M
--1.05M
Non-operating interest expense
88.38%5.37M
--18.33M
--5.26M
--5.16M
--5.06M
--2.85M
--0
--0
--0
--0
Other net income (expense)
-16.96%421K
101.05%1.54M
696.67%717K
181.17%306K
-99.55%8K
171.71%507K
-63.04%765K
-75.21%90K
-156.78%-377K
1,699.09%1.76M
Other non- operating income (expenses)
-16.96%421K
101.05%1.54M
696.67%717K
181.17%306K
-99.55%8K
171.71%507K
-63.04%765K
-75.21%90K
-156.78%-377K
1,699.09%1.76M
Income before tax
-231.84%-138.69M
-19.56%-206.49M
-32.66%-108.99M
-43.50%-103.38M
7.46%47.68M
33.53%-41.79M
-22.62%-172.71M
-29.64%-82.16M
-140.76%-72.05M
265.43%44.37M
Income tax
-19,588.24%-3.31M
-26.45%2.78M
-46.50%2.03M
742K
0
17K
189,150.00%3.79M
189,150.00%3.79M
0
0
Net income
-223.78%-135.38M
-18.57%-209.28M
-29.17%-111.02M
-44.53%-104.13M
7.46%47.68M
33.50%-41.81M
-25.31%-176.49M
-35.61%-85.94M
-140.76%-72.05M
265.43%44.37M
Net income continuous Operations
-223.78%-135.38M
-18.57%-209.28M
-29.17%-111.02M
-44.53%-104.13M
7.46%47.68M
33.50%-41.81M
-25.31%-176.49M
-35.61%-85.94M
-140.76%-72.05M
265.43%44.37M
Minority interest income
-416.87%-2.51M
-828.07%-4M
-209.98%-1.34M
-1.18M
-999K
-486K
-431K
-431K
0
0
Net income attributable to the parent company
-221.51%-132.86M
-16.59%-205.28M
-28.26%-109.68M
-42.89%-102.95M
9.71%48.68M
34.27%-41.33M
-25.00%-176.06M
-34.93%-85.51M
-140.76%-72.05M
265.43%44.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-221.51%-132.86M
-16.59%-205.28M
-28.26%-109.68M
-42.89%-102.95M
9.71%48.68M
34.27%-41.33M
-25.00%-176.06M
-34.93%-85.51M
-140.76%-72.05M
265.43%44.37M
Basic earnings per share
-217.95%-1.24
-14.97%-1.92
-25.93%-1.02
-41.18%-0.96
9.52%0.46
35.00%-0.39
-22.79%-1.67
-32.79%-0.81
-134.48%-0.68
261.54%0.42
Diluted earnings per share
-217.95%-1.24
-14.97%-1.92
-25.93%-1.02
-41.18%-0.96
9.76%0.45
35.00%-0.39
-22.79%-1.67
-32.79%-0.81
-134.48%-0.68
257.69%0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022(Q3)Jun 30, 2022(Q2)Mar 31, 2022
Total revenue -94.32%3.55M-1.03%240.74M-49.02%16.1M-51.18%15.83M-3.65%146.27M127.95%62.55M75.89%243.23M-17.52%31.58M-29.37%32.41M362.66%151.81M
Operating revenue -94.32%3.55M-1.03%240.74M-49.02%16.1M-51.18%15.83M-3.65%146.27M127.95%62.55M75.89%243.23M-17.52%31.58M-29.37%32.41M362.66%151.81M
Cost of revenue
Gross profit
Operating expense 33.83%140.1M5.69%445.74M7.82%124.43M12.54%118.53M-11.02%98.1M15.34%104.68M46.78%421.74M11.86%115.41M35.45%105.32M80.61%110.25M
Selling and administrative expenses 12.69%23.19M-25.96%90.93M-23.58%24.17M-28.62%23.37M-32.62%22.82M-16.31%20.58M51.66%122.82M-17.40%31.62M83.33%32.74M109.16%33.86M
-General and administrative expense 12.69%23.19M-25.96%90.93M-23.58%24.17M-28.62%23.37M-32.62%22.82M-16.31%20.58M51.66%122.82M-17.40%31.62M83.33%32.74M109.16%33.86M
Research and development costs 39.19%116.49M18.80%353.19M19.76%99.86M31.28%94.76M-1.45%74.88M27.26%83.7M44.08%297.31M26.78%83.38M21.67%72.18M70.00%75.99M
Depreciation amortization depletion 2.23%412K0.19%1.62M0.25%405K0.25%404K0.25%405K0.00%403K--1.61M--404K-30.16%403K158.97%404K
-Depreciation and amortization 2.23%412K0.19%1.62M0.25%405K0.25%404K0.25%405K0.00%403K--1.61M--404K-30.16%403K158.97%404K
Operating profit -224.07%-136.55M-14.84%-205M-29.23%-108.33M-40.86%-102.7M15.91%48.17M33.46%-42.13M-19.77%-178.51M-29.20%-83.83M-128.78%-72.91M247.18%41.55M
Net non-operating interest income expense -1,435.93%-2.57M-160.14%-3.03M-186.99%-1.38M-179.52%-986K-147.15%-497K-114.45%-167K-17.76%5.03M37.89%1.58M-3.13%1.24M-30.84%1.05M
Non-operating interest income 4.47%2.8M203.97%15.3M145.42%3.89M236.45%4.17M332.64%4.56M--2.68M-17.76%5.03M--1.58M--1.24M--1.05M
Non-operating interest expense 88.38%5.37M--18.33M--5.26M--5.16M--5.06M--2.85M--0--0--0--0
Other net income (expense) -16.96%421K101.05%1.54M696.67%717K181.17%306K-99.55%8K171.71%507K-63.04%765K-75.21%90K-156.78%-377K1,699.09%1.76M
Other non- operating income (expenses) -16.96%421K101.05%1.54M696.67%717K181.17%306K-99.55%8K171.71%507K-63.04%765K-75.21%90K-156.78%-377K1,699.09%1.76M
Income before tax -231.84%-138.69M-19.56%-206.49M-32.66%-108.99M-43.50%-103.38M7.46%47.68M33.53%-41.79M-22.62%-172.71M-29.64%-82.16M-140.76%-72.05M265.43%44.37M
Income tax -19,588.24%-3.31M-26.45%2.78M-46.50%2.03M742K017K189,150.00%3.79M189,150.00%3.79M00
Net income -223.78%-135.38M-18.57%-209.28M-29.17%-111.02M-44.53%-104.13M7.46%47.68M33.50%-41.81M-25.31%-176.49M-35.61%-85.94M-140.76%-72.05M265.43%44.37M
Net income continuous Operations -223.78%-135.38M-18.57%-209.28M-29.17%-111.02M-44.53%-104.13M7.46%47.68M33.50%-41.81M-25.31%-176.49M-35.61%-85.94M-140.76%-72.05M265.43%44.37M
Minority interest income -416.87%-2.51M-828.07%-4M-209.98%-1.34M-1.18M-999K-486K-431K-431K00
Net income attributable to the parent company -221.51%-132.86M-16.59%-205.28M-28.26%-109.68M-42.89%-102.95M9.71%48.68M34.27%-41.33M-25.00%-176.06M-34.93%-85.51M-140.76%-72.05M265.43%44.37M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -221.51%-132.86M-16.59%-205.28M-28.26%-109.68M-42.89%-102.95M9.71%48.68M34.27%-41.33M-25.00%-176.06M-34.93%-85.51M-140.76%-72.05M265.43%44.37M
Basic earnings per share -217.95%-1.24-14.97%-1.92-25.93%-1.02-41.18%-0.969.52%0.4635.00%-0.39-22.79%-1.67-32.79%-0.81-134.48%-0.68261.54%0.42
Diluted earnings per share -217.95%-1.24-14.97%-1.92-25.93%-1.02-41.18%-0.969.76%0.4535.00%-0.39-22.79%-1.67-32.79%-0.81-134.48%-0.68257.69%0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg